Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-010719
Filing Date
2022-04-22
Accepted
2022-04-22 16:05:24
Documents
4
Period of Report
2022-04-22

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 470869
2 formdef14a_001.jpg GRAPHIC 5701
3 formdef14a_004.jpg GRAPHIC 563323
4 formdef14a_005.jpg GRAPHIC 469132
  Complete submission text file 0001493152-22-010719.txt   1901205
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36357 | Film No.: 22845484
SIC: 2834 Pharmaceutical Preparations